The flu epidemic is taking a toll on the U.S. healthcare system. Here's how health insurers can curtail spending on flu care.
From State-led programs to innovative pharmacist-hospital partnerships, these programs are fighting to quell the epidemic.
CMS unveiled a voluntary episode bundled payment model, Bundled Payments for Care Improvement Advanced (BPCI Advanced). Here’s six things experts want you to know
Pending and recently approved treatment options for patients with chronic obstructive pulmonary disease range from biologics to a triple-drug inhaler.
With influenza activity increasing sharply, here’s how healthcare executives can determine which health plan members are at risk for the flu.
Catherine Bollard, MD, discusses the success rate of CAR T-cell treatments, remaining obstacles, and top payer considerations.
More targeted therapies for autoimmune diseases are on the horizon. Here’s what to anticipate in 2018.
With the right preventions in place, hospitals and healthcare executives will be well positioned to respond to these four risks in 2018.
A new survey has eye-opening findings about the status quo one-size-fits-all health plan.
Fifty percent of Americans have high blood pressure, per new guidelines. Here’s how those guidelines could affect medication utilization and healthcare spending.